Solborn, Inc.
Financials
Valuation Metrics
Solborn, Inc.'s Market Cap is ₩1313B. At end of 2025 it was ₩997B. Ranked #1065 of 2,436 in KR market (top 44%), #544 of 1,649 on KOSDAQ (top 33%), #37 of 96 in Health Care Equipment & Services (top 39%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 131.26B KRW | KR#1,065/2,436 Sec#37/96 |
| Revenue | 131.13B KRW | KR#1,243/2,436 Sec#19/96 |
| Net Income | 52.01B KRW | KR#357/2,436 Sec#4/96 |
| Total Assets | 385.90B KRW | KR#875/2,436 Sec#15/96 |
| Net Assets | 320.99B KRW | KR#674/2,436 Sec#11/96 |
| Employees | 4 | KR#2,282/2,436 Sec#88/96 |
| Value | ||
| P/E | 2.52x | KR#81/2,436 Sec#1/96 |
| P/B | 0.41x | KR#592/2,436 Sec#8/96 |
| P/S | 1.00x | KR#1,394/2,436 Sec#27/96 |
| EV/EBITDA | 3.36x | KR#104/2,436 Sec#2/96 |
| FCF Yield | 11.09% | KR#579/2,436 Sec#11/96 |
| Profitability | ||
| ROE | 16.20% | KR#203/2,436 Sec#11/96 |
| ROA | 13.48% | KR#99/2,436 Sec#11/96 |
| Op. Margin | 26.09% | KR#78/2,436 Sec#6/96 |
| Revenue Growth | 42.22% | KR#350/2,436 Sec#13/96 |
| Earnings Growth | -6.49% | KR#955/2,436 Sec#37/96 |
| Financial Health | ||
| Debt Ratio | 120.22% | KR#658/2,436 Sec#30/96 |
| Total Debt | 590.1M KRW | KR#1,991/2,436 Sec#79/96 |
| FCF | 14.56B KRW | KR#609/2,436 Sec#11/96 |
| Cash | 16.95B KRW | KR#1,342/2,436 Sec#37/96 |
| Current Ratio | 5.50x | KR#259/2,436 Sec#19/96 |
| Net Debt/EBITDA | -0.48x | KR#590/2,436 Sec#23/96 |
| Dividend | ||
| Div. Yield | 0.97% | KR#1,147/2,436 Sec#36/96 |
| Performance | ||
| 1Y Return | 14.56% | KR#472/2,436 Sec#12/96 |
| 1M Return | 25.82% | KR#87/2,436 Sec#6/96 |
| From 52W High | -2.83% | KR#13/2,436 Sec#1/96 |
| 1Y MDD | -26.85% | KR#137/2,436 Sec#3/96 |
| Trading | ||
| Volume | 78,027 shares | KR#1,083/2,436 Sec#45/96 |
| Foreign Own. | 1.44% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 1,136 KRW | KR#579/2,436 Sec#11/96 |
| BPS | 7,924 KRW | KR#1,081/2,436 Sec#24/96 |
Company Info
Solbon, established in 1994 and listed on KOSDAQ in 1999, operates as a holding company headquartered in Gangnam-gu, Seoul. As of 2025, it manages 16 affiliated companies, with specialized subsidiaries in investment business, medical-IT, and media sectors. The company utilizes its holding company structure to enhance management efficiency and drive growth through continuous restructuring. It focuses on maximizing corporate value by identifying and developing promising new businesses based on market and technology trend analysis.